Pharmaceutical Industry

Page 50 of 100

Doctor in white lab coat grips stethoscope
Health

An All-Star Panel Tackles Trump’s Drug Price Plan, Innovation in Health Care—And More

By
May 16, 2018
Johnson And Johnson Recalls Children's Cold Medicines
Health

We Don’t Have a Cure for the Common Cold. But This New Treatment Might Stop It in Its Tracks

By
May 14, 2018
President Trump Delivers Remarks On Lowering Drug Prices In Rose Garden
Health

Why Trump’s Big Drug Price Speech Sent Health Care Stocks Soaring

By
May 11, 2018
IL: Corporations In Illinois
Health

Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever

By
May 8, 2018
Sanofi Presents Its Annual Results
Health

A $14,000 Cholesterol Drug Is Getting A 69% Price Cut

By
May 1, 2018
A Pfizer sign hangs on the outside of their headquarters in New York City.
Health

Why Pfizer and Merck Stock Both Slumped After Their Earnings Reports

By
May 1, 2018
How High Drug Prices and Big Lobbying Budgets Go Together for Big Pharma
Health

How High Drug Prices and Big Lobbying Budgets Go Together for Big Pharma

By Elizabeth Lucas, Jay Hancock, Kaiser Health News and Anne VanderMey
April 26, 2018
Marijuana Cultivation Center In Nevada Ramps Up Production As State Legalizes Recreation Use Of Weed
Health

Epilepsy Drug Made From Marijuana Plant Gets Backing From FDA Staff

By Bloomberg and Wilder Davies
April 17, 2018
Lung cancer on the left pulmonary lobe, seen on a frontal X-ray of the chest.
Health

Merck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer

By
April 16, 2018
Hepatitis C drug can cure, if patients can get it
Health

Hepatitis C Drugs Can Cost $84,000. This New One May Be Just As Good—But Cost $300

By
April 12, 2018
Alzheimers-dementia-brain-research
Health

Researchers Just Proposed a Radical New Way of Defining Alzheimer’s. Could It Lead to Better Drugs?

By
April 10, 2018
This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring
Health

This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring

By
April 9, 2018
Why Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard Of
Health

Why Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard Of

By
April 9, 2018
US-ECONOMY-STOCK MARKET
Health

Why Cancer Drug Maker Incyte’s Stock Plunged—And Took Others Down With It

By
April 6, 2018
Flu Vaccine Shortage Continues
Health

Flu Season Is Still Going Strong

By
March 30, 2018

Most Popular